Original Article
  

Association of Pro-inflammatory Cytokine Gene Polymorphism with Meniere’s Disease in an Iranian Sample

Pro-inflammatory Genes in Meniere’s Disease

Abstract

Meniere’s disease (MD) is known as a rare chronic disorder of the inner ear with elevated serum levels of pro-inflammatory cytokines like tumor necrosis factor (TNF)-α, Interleukin (IL)-1, and IL-6. This study aims to evaluate genes polymorphism in some pro-inflammatory cytokines in a group of Iranian MD patients compared to the healthy controls.
In this case-control study, 25 MD patients and 139 healthy controls were enrolled. DNA was extracted from blood samples, and single nucleotide polymorphisms were detected using polymerase chain reaction with sequence-specific primers assay. MD patients and controls were examined in terms of allele, genotype, and haplotype frequency of pro-inflammatory cytokine genes.
Only the frequencies of alleles A/G at position -238 in the promoter of the TNF-α gene differed significantly between MD patients and healthy controls. G to A allele ratio was 23 and 3.6 in MD and controls, respectively. In individuals with MD, genotype GG was found to be significantly more prevalent at position -238 of the TNF-α gene promoter sequence. In addition, the heterozygote AG variant of -238 A/G TNF-α gene polymorphism was lower in MD patients than controls. Compared to the control group, the haplotype TNF- (-308, -238) AG was higher in MD patients, although not statistically significant.
This is the first study that we know of that evaluates the frequencies of pro-inflammatory cytokine genes in an Iranian MD sample. This study shows the association between TNF-α and susceptibility to MD.

1. Lopez-Escamez JA, Carey J, Chung W-H, Goebel JA, Magnusson M, Mandalà M, et al. Diagnostic criteria for Menière’s disease. J Vestib Res 2015; 25:1–7.
2. Merchant SN, Adams JC, and Nadol JBJ. Pathophysiology of Meniere’s syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005; 26:74–81.
3. Oberman BS, Patel VA, Cureoglu S, and Isildak H. The aetiopathologies of Ménière’s disease: a contemporary review. Acta Otorhinolaryngol Ital 2017; 37:250–263.
4. Flook M and Lopez-Escamez J. Meniere’s Disease: Genetics and the Immune System. Curr Otorhinolaryngol Rep 2018; 6:24–30.
5. Lee JM, Kim MJ, Jung J, Kim HJ, Seo YJ, and Kim SH. Genetic aspects and clinical characteristics of familial Meniere’s disease in a South Korean population. Laryngoscope 2015; 125:2175–2180.
6. Lopez-Escamez JA, Batuecas-Caletrio A, and Bisdorff A. Towards personalized medicine in Ménière’s disease. F1000Research 2018; 7.
7. Tyrrell JS, Whinney DJD, Ukoumunne OC, Fleming LE, and Osborne NJ. Prevalence, associated factors, and comorbid conditions for Ménière’s disease. Ear Hear 2014; 35:e162-9.
8. Gazquez I, Soto-Varela A, Aran I, Santos S, Batuecas A, Trinidad G, et al. High prevalence of systemic autoimmune diseases in patients with Menière’s disease. PLoS One 2011; 6:e26759.
9. Khorsandi M-T, Amoli MM, Borghei H, Emami H, Amiri P, Amirzargar A, et al. Associations between HLA-C alleles and definite Meniere’s disease. Iran J Allergy, Asthma Immunol 2011; 119–122.
10. Chiarella G, Di Domenico M, Petrolo C, Saccomanno M, Rothenberger R, Giordano A, et al. A Proteomics‐Driven Assay Defines Specific Plasma Protein Signatures in Different Stages of Ménière’s Disease. J Cell Biochem 2014; 115:1097–1100.
11. Kim SH, Kim JY, Lee HJ, Gi M, Kim BG, and Choi JY. Autoimmunity as a candidate for the etiopathogenesis of Meniere’s disease: detection of autoimmune reactions and diagnostic biomarker candidate. PLoS One 2014; 9:e111039.
12. Zhou Q, Wang H, Schwartz DM, Stoffels M, Park YH, Zhang Y, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet 2016; 48:67–73.
13. Di Pietro F, Ortenzi F, Tilio M, Concetti F, Napolioni V. Genomic DNA extraction from whole blood stored from 15- to 30-years at -20 degrees C by rapid phenol-chloroform protocol: a useful tool for genetic epidemiology studies. Mol Cell Probes. 2011;25(1).
14. Amirzargar AA, Naroueynejad M, Khosravi F, Dianat SS, Rezaei N, Mytilineos J, et al. Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw 2008; 19:104–112.
15. Furuta T, Teranishi M, Uchida Y, Nishio N, Kato K, Otake H, et al. Association of interleukin-1 gene polymorphisms with sudden sensorineural hearing loss and Ménière’s disease. Int J Immunogenet 2011; 38:249–254.
16. Wang X, Truong T, Billings PB, Harris JP, and Keithley EM. Blockage of immune-mediated inner ear damage by etanercept. Otol Neurotol 2003; 24:52–57.
17. Keithley EM, Wang X, and Barkdull GC. Tumor necrosis factor alpha can induce recruitment of inflammatory cells to the cochlea. Otol Neurotol 2008; 29:854–859.
18. Rahman MU, Poe DS, and Choi HK. Etanercept therapy for immune-mediated cochleovestibular disorders: preliminary results in a pilot study. Otol Neurotol 2001; 22:619–624.
19. Frejo L, Gallego-Martinez A, Requena T, Martin-Sanz E, Amor-Dorado JC, Soto-Varela A, et al. Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease. Sci Rep 2018; 8:5974.
20. Fuse T, Hayashi T, Oota N, Fukase S, Asano S, Kato T, et al. Immunological responses in acute low-tone sensorineural hearing loss and Ménière’s disease. Acta Otolaryngol 2003; 123:26–31.
21. Derebery MJ. Allergic and immunologic features of Ménière’s disease. Otolaryngol Clin North Am 2011; 44:655–66, ix.
22. Requena T, Gazquez I, Moreno A, Batuecas A, Aran I, Soto-Varela A, et al. Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of Meniere’s disease. Immunogenetics 2013; 65:345–355.
23. Gazquez I, Moreno A, Aran I, Soto-Varela A, Santos S, Perez-Garrigues H, et al. MICA-STR A.4 is associated with slower hearing loss progression in patients with Ménière’s disease. Otol Neurotol 2012; 33:223–229.
24. Cabrera S, Sanchez E, Requena T, Martinez-Bueno M, Benitez J, Perez N, et al. Intronic variants in the NFKB1 gene may influence hearing forecast in patients with unilateral sensorineural hearing loss in Meniere’s disease. PLoS One 2014; 9:e112171–e112171.
25. Yazdani N, Khorsandi Ashtiani MT, Zarandy MM, Mohammadi SJ, Ghazavi H, Mahrampour E, et al. Association between MIF gene variation and Meniere’s disease. Int J Immunogenet 2013; 40:488–491.
26. Li L, Wang Y, An L, Kong X, and Huang T. A network-based method using a random walk with restart algorithm and screening tests to identify novel genes associated with Menière’s disease. PLoS One 2017; 12:e0182592.
Files
IssueVol 20 No 6 (2021) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijaai.v20i6.8024
Keywords
Autoimmunity Chemokines Interleukins Meniere disease Polymorphism Tumor necrosis factor-alpha
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Kouhi A, Shakeri S, Yazdani N, Shababi N, Mohseni A, Mohseni A, Sadr M, Mohammad Amoli M, Rezaei A, Rezaei N. Association of Pro-inflammatory Cytokine Gene Polymorphism with Meniere’s Disease in an Iranian Sample. Iran J Allergy Asthma Immunol. 2021;20(6):734-739.